TORONTO, Nov. 17, 2025 (GLOBE NEWSWIRE) — Formic AI today announced its public launch in Canada with an enterprise platform built to deliver trustworthy, explainable search results for enterprise databases that teams can validate with ease. Their “Made-in-Canada” technology provides answers that link back to an organization's own documents for easy review and is engineered […]

(NasdaqGM:CSTL), FRIENDSWOOD, Texas, Nov. 17, 2025 (GLOBE NEWSWIRE) — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has been recognized by the Houston Chronicle as a Houston Top Workplace, which celebrates people-focused, standout workplace cultures. This marks the fifth consecutive year the Company

(NASDAQ:FTRE), DURHAM, N.C., Nov. 17, 2025 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced the appointment of Agnieszka (Aggie) M. Gallagher as general counsel. Gallagher is responsible for the Company's legal strategy and operations, serving as corporate secretary, chief compliance officer and as a member of

(NASDAQ:SEV), Reports Q3 2025 GAAP Net Loss of $5.5 Million and Nine-Month Net Loss of $28.4 Million Calculates Q3 2025 Adjusted Net Loss of $2.9 Million (Non-GAAP) and Nine-Month Adjusted Net Loss of $10.2 Million (Non-GAAP) Recognized $2.5 Million in Other Income for Q3 and $4.6 Million for Nine Months primarily from California Energy Commission

(Other OTC:MHCUF),(OTC US:MHCUF),(TSX:MHC-U),(TSX:MHC-UN), Not for distribution to U.S. newswire services or dissemination in the United States. TORONTO, Nov. 17, 2025 (GLOBE NEWSWIRE) — Flagship Communities Real Estate Investment Trust (“Flagship” or the “REIT“) (TSX:MHC.U) (TSX:MHC.UN) today announced a cash distribution of US$0.0545 per REIT unit for the month of November 2025, representing US$0.654 per REIT

(NASDAQ:IMTX), Anzu-cel (anzutresgene autoleucel, IMA203) PRAME Cell Therapy: Global, randomized, controlled Phase 3 trial, SUPRAME, in previously treated advanced melanoma ongoing; interim and final analyses will occur in 2026 Anzu-cel (IMA203) PRAME Cell Therapy: One-time infusion continues to show strong clinical benefit and favorable tolerability in 16 patients with metastatic uveal melanoma in latest update

Save Up to 21% This Black Friday on TORRAS OrigArmor: The World's First 3D Curved Anti-Reflective Screen Protector GlobeNewswire November 17, 2025 Los Angeles, Nov. 17, 2025 (GLOBE NEWSWIRE) — This Black Friday, TORRAS is making waves with a game-changing offer on its latest innovation – the OrigArmor Screen Protector, the world's first anti-reflective screen

SolarMax Technology Reports Third Quarter 2025 Financial Results GlobeNewswire November 17, 2025 RIVERSIDE, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) — SolarMax Technology, Inc. (Nasdaq SMXT) (“SolarMax” or the “Company”), an integrated solar energy company, reported financial results for the quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights Revenue: $30.6 million, up 383% from

Luckin Coffee Announces Third Quarter 2025 Financial Results GlobeNewswire November 17, 2025 Net Revenues Increased by 50.2% Year-over-Year to RMB15.3 Billion Average Monthly Transacting Customers Reached a Record High of 112.3 Million 3,008 Net New Store Openings; Ended Quarter with 29,214 Stores BEIJING, Nov. 17, 2025 (GLOBE NEWSWIRE) — Luckin Coffee Inc. (“Luckin Coffee” or

AlorAir Showcases Comprehensive Clean Air Solutions at ISSA Show North America 2025 GlobeNewswire November 17, 2025 Las Vegas, Nov. 17, 2025 (GLOBE NEWSWIRE) — From November 10-13, AlorAir, a leading manufacturer of restoration and indoor air quality solutions, exhibited at the ISSA Show North America 2025, held at the Mandalay Bay Convention Center in Las